Healthcare · Medical - Equipment & Services
Price
$10.88
Market Cap
$982.7M
Employees
118
Beta
1.20
Avg Volume
721,972
CEO
Uzi Sofer
Business Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Business History
Price Overview
Last updated: Jun 27, 2026 8:58am (just now)$10.88
-0.29 (-2.60%)
Day Range
$10.61 – $11.30
52-Week Range
$2.87 – $11.62
50-Day MA
$9.32
200-Day MA
$6.50
Volume
486,096.00
Analyst Price Targets
Low
$8.00
Consensus
$13.33
High
$17.00
(8 analysts)
Share Structure
Outstanding
90,325,876.00
Float
61,831,024.00
Free Float
68.5%
Normal free float
— 68.5% of shares trade freely, ~31.5% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-20.53
Stock Price: $10.88
EPS (Diluted): -0.53
EPS (Diluted): -0.53
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
5.17
Stock Price: $10.88
Total Equity: $77.10M
Shares: 80,581,440
Total Equity: $77.10M
Shares: 80,581,440
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-22.00
Market Cap: $982.75M
Total Debt: $6.35M
Cash: $15.98M
EBITDA: -$41.06M
Total Debt: $6.35M
Cash: $15.98M
EBITDA: -$41.06M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$988.6M
Market Cap: $982.75M
Total Debt: $6.35M
Cash: $15.98M
Total Debt: $6.35M
Cash: $15.98M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.00
Stock Price: $10.88
Revenue: $0.00
Shares: 80,581,440
Revenue: $0.00
Shares: 80,581,440
EV/Sales (Total value vs revenue — works when P/E can't)
API0.00
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
0.0%
Gross Profit: -$1.23M
Revenue: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
0.0%
Operating Income: -$42.29M
Revenue: $0.00
Revenue: $0.00
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
0.0%
Net Income: -$42.63M
Revenue: $0.00
Revenue: $0.00
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-73.2%
Net Income: -$42.63M
Total Equity: $77.10M
Total Equity: $77.10M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-46.5%
Operating Income: -$42.29M
Tax Rate: -0.3%
Equity: $77.10M
Total Debt: $6.35M
Cash: $15.98M
Tax Rate: -0.3%
Equity: $77.10M
Total Debt: $6.35M
Cash: $15.98M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
7.79
Current Assets: $78.30M
Current Liabilities: $10.51M
Current Liabilities: $10.51M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.08
Short-Term Debt: $0.00
Long-Term Debt: $6.35M
Total Debt: $6.35M
Total Equity: $77.10M
Long-Term Debt: $6.35M
Total Debt: $6.35M
Total Equity: $77.10M
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 80,581,440
Shares: 80,581,440
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.96
Total Equity: $77.10M
Shares: 80,581,440
Shares: 80,581,440
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.41
Operating CF: -$26.68M
CapEx: -$6.08M
Shares: 80,581,440
CapEx: -$6.08M
Shares: 80,581,440
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $10.88
Stock Price: $10.88
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$42.63M
Net Income: -$42.63M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares DRTS against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 24, 2026 4:04am (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $776,000 | $979,000 | $1.1M | $1.1M | $1.2M |
| Gross Profit | $-776,000 | $-979,000 | -$1.1M | -$1.1M | -$1.2M |
| Operating Expenses | $13.8M | $32.1M | $34.6M | $34.9M | $41.1M |
| Operating Income | -$13.8M | -$32.1M | $35.7M | -$36.0M | -$42.3M |
| Net Income | -$27.3M | -$33.8M | -$29.2M | -$31.8M | -$42.6M |
| EBITDA | -$13.2M | -$32.7M | -$28.0M | -$30.3M | -$41.1M |
| EPS | $-0.67 | $-0.53 | $-0.42 | $-0.45 | $-0.53 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 24, 2026 4:04am (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $23.2M | $5.8M | $12.7M | $13.7M | $16.0M |
| Total Current Assets | $32.6M | $106.5M | $85.8M | $64.2M | $78.3M |
| Total Assets | $42.2M | $120.1M | $107.4M | $86.2M | $106.6M |
| Current Liabilities | $4.4M | $4.3M | $7.1M | $8.7M | $10.5M |
| Long-Term Debt | $54.0M | $0 | $5.6M | $5.6M | $6.4M |
| Total Liabilities | $77.0M | $14.5M | $22.9M | $23.5M | $29.5M |
| Total Equity | -$34.8M | $105.7M | $84.5M | $62.7M | $77.1M |
| Retained Earnings | -$52.8M | -$86.6M | -$115.8M | -$147.5M | -$190.1M |
Cash Flow (Annual)
Last updated: Jun 24, 2026 4:04am (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$11.8M | -$23.9M | -$18.0M | -$19.8M | -$26.7M |
| Capital Expenditure | -$2.9M | $-904,000 | -$6.4M | -$2.2M | -$6.1M |
| Free Cash Flow | -$14.7M | -$24.8M | -$24.4M | -$22.0M | -$32.8M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $7.7M | -$17.2M | $9.1M | $1.2M | -$1.0M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:58am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$12.4M $12.4M – $12.4M
|
$72.9M $72.9M – $72.9M
|
$142.6M $142.6M – $142.6M
|
$258.7M $258.7M – $258.7M
|
| EBITDA | $0 | $0 | $0 | $0 |
| Net Income |
-$41.5M -$44.7M – -$35.8M
|
-$5.5M -$5.5M – -$5.5M
|
$20.1M $20.1M – $20.1M
|
$70.9M $70.9M – $70.9M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 24, 2026 4:04am (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | — | — |
| Gross Profit Growth | -26.2% | -9.7% | -2.6% | -11.8% |
| Operating Income Growth | -133.0% | +211.0% | -201.0% | -17.3% |
| Net Income Growth | -23.8% | +13.6% | -8.9% | -34.3% |
| EBITDA Growth | -147.8% | +14.4% | -8.1% | -35.5% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for DRTS — it's generated by the pipeline (
market-narrative step).
No community reviews yet for DRTS.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30